Pharmaceutical Industry Blog

Last Updated: June 28, 2026 TL;DR: Meloxicam Injection - a sterile, clear yellow aqueous solution of meloxicam, an enolic-acid oxicam NSAID with preferential COX-2 activity, solubilised with meglumine and supplied commonly as a 15 mg/1.5 mL ampoule (10 mg/mL) given by deep intramuscular injection - is the once-daily, strong non-opioid anti-inflammatory clinicians use for the short-term symptomatic treatment of painful exacerbations of osteoarthritis, rheumatoid arthritis and

Last Updated: June 28, 2026 TL;DR: Etoricoxib Injection - a sterile, ready-to-use aqueous solution of etoricoxib, one of the most COX-2 selective of the coxib NSAIDs, supplied commonly as a 60 mg/2 mL ampoule (30 mg/mL) given by deep intramuscular injection - is the strong, non-opioid analgesic and anti-inflammatory clinicians use for the short-term control of acute pain and the painful flares of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gout, whe

Last Updated: June 27, 2026 TL;DR: Parecoxib for Injection - a sterile, lyophilized powder of parecoxib sodium, the water-soluble prodrug of valdecoxib and the only injectable selective COX-2 inhibitor (coxib) in clinical use, supplied commonly as a 40 mg vial reconstituted with 2 mL of 0.9% sodium chloride and given intravenously or intramuscularly - is the non-opioid analgesic clinicians use for the short-term management of acute post-operative pain, where COX-2 selectivity

Last Updated: June 27, 2026 TL;DR: Lornoxicam for Injection - a sterile, lyophilized yellow powder of lornoxicam, a potent oxicam-class non-steroidal anti-inflammatory drug (NSAID) that inhibits both COX-1 and COX-2, supplied commonly as an 8 mg vial reconstituted with 2 mL water for injection to a 4 mg/mL solution and given intravenously or intramuscularly - is the short-acting, strongly analgesic NSAID clinicians reach for to control moderate-to-severe acute and post-operat

Last Updated: June 25, 2026 TL;DR: Rocuronium Bromide Injection - a sterile, clear, colourless to slightly yellow aqueous solution of rocuronium bromide, a non-depolarising aminosteroid neuromuscular blocking agent, supplied commonly as a 10 mg/mL solution (for example 50 mg in a 5 mL vial or 100 mg in a 10 mL vial) given intravenously - is the rapid-onset, intermediate-duration muscle relaxant anaesthetists use to ease tracheal intubation and to maintain surgical relaxation,

Last Updated: June 25, 2026 TL;DR: Succinylcholine Chloride Injection — also known as suxamethonium chloride, a sterile aqueous solution of the only depolarising neuromuscular blocking agent in routine clinical use, supplied commonly as a 50 mg/mL solution (for example 100 mg in a 2 mL ampoule or 500 mg in a 10 mL vial) given intravenously — is the ultra-short-acting muscle relaxant anaesthetists rely on for rapid-sequence induction and tracheal intubation, where it produces